Related Experiment Videos
Antitumor activity of cytogenin
H Kumagai1, T Masuda, M Ishizuka
1Institute for Chemotherapy, M.C.R.F., Shizuoka, Japan.
The Journal of Antibiotics
|February 1, 1995
Summary
Cytogenin demonstrates antitumor effects against IMC carcinoma in mice through host-mediated mechanisms, involving macrophages and T cells, rather than direct tumor cell killing.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Cytogenin's antitumor properties were investigated.
- The compound showed no direct cytotoxicity to tumor cells in vitro or significant toxicity in vivo, suggesting a host-mediated mechanism.
Purpose of the Study:
- To investigate the antitumor effect of cytogenin against IMC carcinoma in mice.
- To elucidate the mechanism of action and identify the immune cells involved.
Main Methods:
- Oral administration of cytogenin to mice bearing IMC carcinoma.
- Evaluation of antitumor activity based on administration schedule.
- Assessment of cytogenin's effect in immunosuppressed mice (anti-asialo GM1 serum, athymic mice) and irradiated mice.
Main Results:
- Cytogenin exhibited antitumor activity against IMC carcinoma in a schedule-dependent manner.
- Optimal efficacy was achieved with specific administration timings and frequencies.
- The antitumor effect was diminished in immunosuppressed mice but not in irradiated mice.
- Activated effector cells were identified as macrophages and T cells.
Conclusions:
- Cytogenin's antitumor effect is mediated by the host immune system.
- Macrophages and T cells play a crucial role in cytogenin's anti-IMC carcinoma activity.
- The findings support cytogenin as a potential immunomodulatory agent for cancer therapy.